During the past decade, Covenant Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covenant Medical Center" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "W.L.Gore & Associates" with 3 trials sponsored, "Alexion" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Osteal Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covenant Medical Center" #1 collaborator was "Daiichi Sankyo, Inc." with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Covenant Medical Center" are "Coronary Artery Disease" (7 trials), "Coronary Disease" (3 trials), "Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Covenant Medical Center" in a lesser frequency.

Most popular intervention types in "Covenant Medical Center" are "Drug" (21 trials), "Device" (12 trials), "Other" (5 trials), "Behavioral" (2 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Laboratory Biomarker Analysis" (2 trials), "Apixaban" (1 trials), "Aspirin" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covenant Medical Center" are 37 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Covenant Medical Center". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Covenant Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Covenant Medical Center, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".

Covenant Medical Center has several departments that took part in Clinical trials: "Covenant Center for the Heart" - 2 trials